135 related articles for article (PubMed ID: 11148823)
1. [Liver changes in heterozygote alpha 1-antitrypsin deficiency PiZ].
Zhou H; Fischer HP
Pathologe; 2000 Nov; 21(6):433-40. PubMed ID: 11148823
[TBL] [Abstract][Full Text] [Related]
2. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?
Zhou H; Ortiz-Pallardó ME; Ko Y; Fischer HP
Cancer; 2000 Jun; 88(12):2668-76. PubMed ID: 10870048
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ.
Fischer HP; Ortiz-Pallardó ME; Ko Y; Esch C; Zhou H
J Hepatol; 2000 Dec; 33(6):883-92. PubMed ID: 11131449
[TBL] [Abstract][Full Text] [Related]
4. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency.
Zhou H; Fischer HP
Am J Surg Pathol; 1998 Jun; 22(6):742-8. PubMed ID: 9630182
[TBL] [Abstract][Full Text] [Related]
5. Detection of alpha-1-antitrypsin PiZ individuals by SSCP and DNA sequencing in formalin-fixed and paraffin-embedded tissue: a comparison with immunohistochemical analysis.
Ortiz-Pallardó ME; Ko Y; Sachinidis A; Vetter H; Fischer HP; Zhou H
J Hepatol; 2000 Mar; 32(3):406-11. PubMed ID: 10735609
[TBL] [Abstract][Full Text] [Related]
6. Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis.
Elzouki AN; Hultcrantz R; Stål P; Befrits R; Eriksson S
Gut; 1995 Jun; 36(6):922-6. PubMed ID: 7615285
[TBL] [Abstract][Full Text] [Related]
7. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort.
Clark VC; Marek G; Liu C; Collinsworth A; Shuster J; Kurtz T; Nolte J; Brantly M
J Hepatol; 2018 Dec; 69(6):1357-1364. PubMed ID: 30138687
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1-antitrypsin deficiency: from genoma to liver disease. PiZ mouse as model for the development of liver pathology in human.
Giovannoni I; Callea F; Stefanelli M; Mariani R; Santorelli FM; Francalanci P
Liver Int; 2015 Jan; 35(1):198-206. PubMed ID: 24529185
[TBL] [Abstract][Full Text] [Related]
10. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP
Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245
[TBL] [Abstract][Full Text] [Related]
11. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
[TBL] [Abstract][Full Text] [Related]
12. Detection of Pi Z phenotype individuals by alpha-1-antitrypsin (AAT) immunohistochemistry in paraffin-embedded liver tissue specimens.
Callea F; Fevery J; De Groote J; Desmet VJ
J Hepatol; 1986; 2(3):389-401. PubMed ID: 2424968
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of children with α-1 antitrypsin deficiency.
Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
15. Rapid analysis of alpha1-antitrypsin PiZ genotype by a real-time PCR approach.
Ortiz-Pallardó ME; Zhou H; Fischer HP; Neuhaus T; Sachinidis A; Vetter H; Brüning T; Ko Y
J Mol Med (Berl); 2000; 78(4):212-6. PubMed ID: 10933583
[TBL] [Abstract][Full Text] [Related]
16. Correcting the PiZ defect in the alpha 1-antitrypsin gene of human cells by targeted homologous recombination.
Savransky E; Hytiroglou P; Harpaz N; Thung SN; Johnson EM
Lab Invest; 1994 May; 70(5):676-83. PubMed ID: 8196364
[TBL] [Abstract][Full Text] [Related]
17. Serine protease inhibitors in patients with chronic viral hepatitis.
Elzouki AN; Verbaan H; Lindgren S; Widell A; Carlson J; Eriksson S
J Hepatol; 1997 Jul; 27(1):42-8. PubMed ID: 9252072
[TBL] [Abstract][Full Text] [Related]
18. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression.
Volkert I; Fromme M; Schneider C; Candels L; Lindhauer C; Su H; Thorhauge K; Pons M; Mohamed MR; Schneider KM; Strnad P; Trautwein C
Hepatology; 2024 Apr; 79(4):898-911. PubMed ID: 37625151
[TBL] [Abstract][Full Text] [Related]
19. [Liver alterations due to alpha-1-antitrypsin deficiency in adults. Study of 5 patients and analysis of the cases reported in the Spanish literature].
Cosme A; Ojeda E; Torrado J; Carrera A; Castiella A; Zapata E
Gastroenterol Hepatol; 2003 Apr; 26(4):251-6. PubMed ID: 12681119
[TBL] [Abstract][Full Text] [Related]
20. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
Marwick TH; Cooney PT; Kerlin P
Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
